report cover

Hospital-acquired infections (HAIs) Control Market - Global Outlook and Forecast 2022-2028

  • 23 February 2022
  • ICT & Media
  • 68 Pages
  • Report code : 24WT-6906701

Hospital-acquired infections Control Market

1 Introduction to Research & Analysis Reports
1.1 Hospital-acquired infections (HAIs) Control Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hospital-acquired infections (HAIs) Control Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hospital-acquired infections (HAIs) Control Overall Market Size
2.1 Global Hospital-acquired infections (HAIs) Control Market Size: 2021 VS 2028
2.2 Global Hospital-acquired infections (HAIs) Control Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hospital-acquired infections (HAIs) Control Players in Global Market
3.2 Top Global Hospital-acquired infections (HAIs) Control Companies Ranked by Revenue
3.3 Global Hospital-acquired infections (HAIs) Control Revenue by Companies
3.4 Top 3 and Top 5 Hospital-acquired infections (HAIs) Control Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hospital-acquired infections (HAIs) Control Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hospital-acquired infections (HAIs) Control Players in Global Market
3.6.1 List of Global Tier 1 Hospital-acquired infections (HAIs) Control Companies
3.6.2 List of Global Tier 2 and Tier 3 Hospital-acquired infections (HAIs) Control Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Hospital-acquired infections (HAIs) Control Market Size Markets, 2021 & 2028
4.1.2 Diagnostic techniques
4.1.3 Dleaning and sterilization
4.1.4 Treatment
4.2 By Type - Global Hospital-acquired infections (HAIs) Control Revenue & Forecasts
4.2.1 By Type - Global Hospital-acquired infections (HAIs) Control Revenue, 2017-2022
4.2.2 By Type - Global Hospital-acquired infections (HAIs) Control Revenue, 2023-2028
4.2.3 By Type - Global Hospital-acquired infections (HAIs) Control Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hospital-acquired infections (HAIs) Control Market Size, 2021 & 2028
5.1.2 General Hospital
5.1.3 Infectious Disease Hospital
5.2 By Application - Global Hospital-acquired infections (HAIs) Control Revenue & Forecasts
5.2.1 By Application - Global Hospital-acquired infections (HAIs) Control Revenue, 2017-2022
5.2.2 By Application - Global Hospital-acquired infections (HAIs) Control Revenue, 2023-2028
5.2.3 By Application - Global Hospital-acquired infections (HAIs) Control Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Hospital-acquired infections (HAIs) Control Market Size, 2021 & 2028
6.2 By Region - Global Hospital-acquired infections (HAIs) Control Revenue & Forecasts
6.2.1 By Region - Global Hospital-acquired infections (HAIs) Control Revenue, 2017-2022
6.2.2 By Region - Global Hospital-acquired infections (HAIs) Control Revenue, 2023-2028
6.2.3 By Region - Global Hospital-acquired infections (HAIs) Control Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Hospital-acquired infections (HAIs) Control Revenue, 2017-2028
6.3.2 US Hospital-acquired infections (HAIs) Control Market Size, 2017-2028
6.3.3 Canada Hospital-acquired infections (HAIs) Control Market Size, 2017-2028
6.3.4 Mexico Hospital-acquired infections (HAIs) Control Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Hospital-acquired infections (HAIs) Control Revenue, 2017-2028
6.4.2 Germany Hospital-acquired infections (HAIs) Control Market Size, 2017-2028
6.4.3 France Hospital-acquired infections (HAIs) Control Market Size, 2017-2028
6.4.4 U.K. Hospital-acquired infections (HAIs) Control Market Size, 2017-2028
6.4.5 Italy Hospital-acquired infections (HAIs) Control Market Size, 2017-2028
6.4.6 Russia Hospital-acquired infections (HAIs) Control Market Size, 2017-2028
6.4.7 Nordic Countries Hospital-acquired infections (HAIs) Control Market Size, 2017-2028
6.4.8 Benelux Hospital-acquired infections (HAIs) Control Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Hospital-acquired infections (HAIs) Control Revenue, 2017-2028
6.5.2 China Hospital-acquired infections (HAIs) Control Market Size, 2017-2028
6.5.3 Japan Hospital-acquired infections (HAIs) Control Market Size, 2017-2028
6.5.4 South Korea Hospital-acquired infections (HAIs) Control Market Size, 2017-2028
6.5.5 Southeast Asia Hospital-acquired infections (HAIs) Control Market Size, 2017-2028
6.5.6 India Hospital-acquired infections (HAIs) Control Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Hospital-acquired infections (HAIs) Control Revenue, 2017-2028
6.6.2 Brazil Hospital-acquired infections (HAIs) Control Market Size, 2017-2028
6.6.3 Argentina Hospital-acquired infections (HAIs) Control Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hospital-acquired infections (HAIs) Control Revenue, 2017-2028
6.7.2 Turkey Hospital-acquired infections (HAIs) Control Market Size, 2017-2028
6.7.3 Israel Hospital-acquired infections (HAIs) Control Market Size, 2017-2028
6.7.4 Saudi Arabia Hospital-acquired infections (HAIs) Control Market Size, 2017-2028
6.7.5 UAE Hospital-acquired infections (HAIs) Control Market Size, 2017-2028
7 Players Profiles
7.1 STERIS Corporation
7.1.1 STERIS Corporation Corporate Summary
7.1.2 STERIS Corporation Business Overview
7.1.3 STERIS Corporation Hospital-acquired infections (HAIs) Control Major Product Offerings
7.1.4 STERIS Corporation Hospital-acquired infections (HAIs) Control Revenue in Global Market (2017-2022)
7.1.5 STERIS Corporation Key News
7.2 Advanced Sterilization Products Division
7.2.1 Advanced Sterilization Products Division Corporate Summary
7.2.2 Advanced Sterilization Products Division Business Overview
7.2.3 Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Major Product Offerings
7.2.4 Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Revenue in Global Market (2017-2022)
7.2.5 Advanced Sterilization Products Division Key News
7.3 Hoffmann-La Roche
7.3.1 Hoffmann-La Roche Corporate Summary
7.3.2 Hoffmann-La Roche Business Overview
7.3.3 Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Major Product Offerings
7.3.4 Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Revenue in Global Market (2017-2022)
7.3.5 Hoffmann-La Roche Key News
7.4 Pfizer
7.4.1 Pfizer Corporate Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Hospital-acquired infections (HAIs) Control Major Product Offerings
7.4.4 Pfizer Hospital-acquired infections (HAIs) Control Revenue in Global Market (2017-2022)
7.4.5 Pfizer Key News
7.5 Becton Dickinson
7.5.1 Becton Dickinson Corporate Summary
7.5.2 Becton Dickinson Business Overview
7.5.3 Becton Dickinson Hospital-acquired infections (HAIs) Control Major Product Offerings
7.5.4 Becton Dickinson Hospital-acquired infections (HAIs) Control Revenue in Global Market (2017-2022)
7.5.5 Becton Dickinson Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Ask Our Expert

Leave This Empty:

*Required Information
List of Tables
Table 1. Hospital-acquired infections (HAIs) Control Market Opportunities & Trends in Global Market
Table 2. Hospital-acquired infections (HAIs) Control Market Drivers in Global Market
Table 3. Hospital-acquired infections (HAIs) Control Market Restraints in Global Market
Table 4. Key Players of Hospital-acquired infections (HAIs) Control in Global Market
Table 5. Top Hospital-acquired infections (HAIs) Control Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hospital-acquired infections (HAIs) Control Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hospital-acquired infections (HAIs) Control Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hospital-acquired infections (HAIs) Control Product Type
Table 9. List of Global Tier 1 Hospital-acquired infections (HAIs) Control Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hospital-acquired infections (HAIs) Control Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hospital-acquired infections (HAIs) Control Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hospital-acquired infections (HAIs) Control Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hospital-acquired infections (HAIs) Control Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hospital-acquired infections (HAIs) Control Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hospital-acquired infections (HAIs) Control Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hospital-acquired infections (HAIs) Control Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2023-2028
Table 30. STERIS Corporation Corporate Summary
Table 31. STERIS Corporation Hospital-acquired infections (HAIs) Control Product Offerings
Table 32. STERIS Corporation Hospital-acquired infections (HAIs) Control Revenue (US$, Mn), (2017-2022)
Table 33. Advanced Sterilization Products Division Corporate Summary
Table 34. Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Product Offerings
Table 35. Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Revenue (US$, Mn), (2017-2022)
Table 36. Hoffmann-La Roche Corporate Summary
Table 37. Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Product Offerings
Table 38. Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Revenue (US$, Mn), (2017-2022)
Table 39. Pfizer Corporate Summary
Table 40. Pfizer Hospital-acquired infections (HAIs) Control Product Offerings
Table 41. Pfizer Hospital-acquired infections (HAIs) Control Revenue (US$, Mn), (2017-2022)
Table 42. Becton Dickinson Corporate Summary
Table 43. Becton Dickinson Hospital-acquired infections (HAIs) Control Product Offerings
Table 44. Becton Dickinson Hospital-acquired infections (HAIs) Control Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Hospital-acquired infections (HAIs) Control Segment by Type in 2021
Figure 2. Hospital-acquired infections (HAIs) Control Segment by Application in 2021
Figure 3. Global Hospital-acquired infections (HAIs) Control Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hospital-acquired infections (HAIs) Control Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hospital-acquired infections (HAIs) Control Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hospital-acquired infections (HAIs) Control Revenue in 2021
Figure 8. By Type - Global Hospital-acquired infections (HAIs) Control Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hospital-acquired infections (HAIs) Control Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hospital-acquired infections (HAIs) Control Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hospital-acquired infections (HAIs) Control Revenue Market Share, 2017-2028
Figure 12. US Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hospital-acquired infections (HAIs) Control Revenue Market Share, 2017-2028
Figure 16. Germany Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2017-2028
Figure 17. France Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hospital-acquired infections (HAIs) Control Revenue Market Share, 2017-2028
Figure 24. China Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2017-2028
Figure 28. India Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hospital-acquired infections (HAIs) Control Revenue Market Share, 2017-2028
Figure 30. Brazil Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hospital-acquired infections (HAIs) Control Revenue Market Share, 2017-2028
Figure 33. Turkey Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hospital-acquired infections (HAIs) Control Revenue, (US$, Mn), 2017-2028
Figure 37. STERIS Corporation Hospital-acquired infections (HAIs) Control Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pfizer Hospital-acquired infections (HAIs) Control Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Becton Dickinson Hospital-acquired infections (HAIs) Control Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Hospital-acquired infections Control Market

Leave This Empty: